Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study

Abstract

BackgroundHepatocellular carcinoma is a highly progressive cancer in the case of late diagnosis which is frequently associated with HBV and HCV viral infections.ObjectivesTo identify differentially expressed serum proteins among three main stages of HCV infection and healthy individuals, and their comparisons with sera from patients with the same stage of HBV infection.Patients and MethodsTwo-dimensional polyacrylamide gel electrophoresis combined with liquid chromatography-tandem mass spectrometry was performed on 47 sera from healthy volunteers, those with chronic active hepatitis, cirrhosis and HCC patients associated with HBV and HCV infections.ResultsAmong these, 62 spots were differentially expressed (≥ 1.5 fold; P < 0.05), of which 42 spots that corresponded to 15 proteins were identified by liquid chromatography-tandem mass spectrometry. CD5-like antigen (CD5L) was differentially expressed between cirrhosis and HCC patients with HCV infection. Leucine-rich α2-glycoprotein (LRG) and haptoglobin (HP) α2 isoforms differed in the HCC that was associated with either HCV or HBV infections.ConclusionsCD5L might be a useful biomarker for early diagnosis of HCC in HCV cirrhotic patients. LRG and HP α2 isoforms could be potential markers for distinguishing viral HCC. Our results also further support the presence of varying molecules involved in hepatocarcinogenesis in HBV when compared with HCV infection.

Clinical Impact of Alcohol‐Related Cirrhosis in the Next Decade: Estimates Based on Current Epidemiological Trends in the United States

“…Finally, since HBV and HCV are major causes of hepatocellular carcinoma (HCC) (Sarvari et al, 2013), the most rapidly increasing indication for liver transplantation, a reduction in prevalence of the underlying diseases will result in a lower number of patients due to viral hepatitis and HCC who are either listed or undergo liver transplantation.…”

The human CD5L/AIM-CD36 axis: A novel autophagy inducer in macrophages that modulates inflammatory responses

“…In mouse models and in humans, elevated levels of CD5L occur in conditions with inflammatory components such as LPSinduced fulminant hepatitis 20 , M. tuberculosis infection, 53 obesity, 25 liver cirrhosis, 12,13,62 and allergic asthma, 63 among others. Therefore, in these scenarios, high expression of CD5L may act in an autocrine fashion on MF to modulate inflammatory responses.…”

Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging

“…To date, new biomarkers for fibrosis have been sought primarily by using differential twodimensional gel electrophoresis (2D-GE) separations of tissues or serum together with mass spectrometry for protein identification [28,29]. Proteomic analysis of plasma or serum derived from HCV-infected subjects is an emerging technique for the identification of biomarkers indicative of disease progression and severity [23,[30][31][32][33]. Using plasma samples from clinically defined patients of fibrosis progression by biopsy, we have obtained results that support the potential use of SELDI-TOF MS profiling as a tool to follow disease progression.…”